Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
USANA Philippines Earns Three Major Awards for Corporate Excellence 2022-09-23 09:00
Shandong Proton Center Celebrates Milestone in Delivering High-Quality Proton Treatment 2022-09-23 08:00
WINNERS OF THE 2023 BREAKTHROUGH PRIZES IN LIFE SCIENCES, MATHEMATICS AND FUNDAMENTAL PHYSICS ANNOUNCED 2022-09-22 21:25
Frost & Sullivan Explores the Growing Impact of the Digital Front Door on Healthcare 2022-09-22 17:14
NIA Accelerates Thai FoodTech Startups to Steer Bangkok Towards Becoming FoodTech Silicon Valley Through SPACE-F Project 2022-09-22 15:47
Clarivate Supports Peer Review Week by Raising the Profile of Peer Reviewers 2022-09-22 15:00
Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 2022-09-22 13:59
Gates Foundation Announces $1.27 Billion in Health and Development Commitments to Advance Progress Toward the Global Goals 2022-09-22 06:36
Heads of State Commit to Noncommunicable Disease Global Compact to Save 50 Million Lives by 2030 2022-09-21 20:12
Far Eastern New Century won the "Sustainability & Innovation Award" from ITMF Awards 2022 with FENC® TOPGREEN® Bio3 2022-09-21 20:00
JDRF Announces Launch of Global Type 1 Diabetes Index 2022-09-21 19:55
Ivory Dentin Graft(TM), the First and Only Dentin Graft, Receives CE Mark 2022-09-21 18:20
MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19 2022-09-21 17:13
HIKE Capital rides green wave to seize future 2022-09-21 13:53
Love Your Heart event to offer tips on overall and heart health 2022-09-21 13:00
Excelra partners with Patcore, Inc. 2022-09-21 12:30
SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore 2022-09-21 11:00
Final IPAX-1 Study Data Confirms Safety and Tolerability Profile for TLX101, Preliminary Efficacy Data 2022-09-21 07:51
Glyscend Therapeutics Releases New Phase 1 Biomarker Results and Initiates Phase 2 Clinical Trial under an IND for GLY-200 as a Potential First-in-Class Type 2 Diabetes Treatment 2022-09-21 05:33
Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead(TM) Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference 2022-09-20 22:40
1 165 166 167 168 169 740